Navigant Biotech awarded $2 million.

Navigant Biotechnologies Inc. of Lakewood has been awarded $2 million from the U.S. Department of Defense to develop and test military applications for the company's emerging Mirasol[TM] Pathogen Reduction Technology. Mirasol PRT is a proprietary technology that uses riboflavin and light to remove pathogens from collected blood, improving the safety of transfused blood.